NCT/Study#
N/A /
OBS16577
A non-interventional, multinational, observational study with isatuximab in patients with relapsed and/or refractory multiple myeloma (RRMM)
DISEASE GROUP:
RRMM
current phase:
Observational Study
STUDY STATUS:
Closed to Enrollment
Location:
Freehold, NJ
For More information:
Call (201) 518-3587
